103 related articles for article (PubMed ID: 22706294)
1. Cervical human papillomavirus infection and shedding of human immunodeficiency virus in cervicovaginal fluids: a cross-sectional study.
Fornabaio C; Carvalho AC; Lillo F; Fiore JR; Bergamaschi V; Bigoni S; Puzzi PR; Cristini G; Comelli M; Parisi MR; Matteelli A
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):78-82. PubMed ID: 22706294
[TBL] [Abstract][Full Text] [Related]
2. Correlates of human immunodeficiency virus cervicovaginal shedding among postmenopausal and fertile-aged women.
Melo KC; Melo MR; Ricci BV; Segurado AC
Menopause; 2012 Feb; 19(2):150-6. PubMed ID: 21983010
[TBL] [Abstract][Full Text] [Related]
3. HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.
Prazuck T; Chaillon A; Avettand-Fènoël V; Caplan AL; Sayang C; Guigon A; Niang M; Barin F; Rouzioux C; Hocqueloux L
PLoS One; 2013; 8(8):e69686. PubMed ID: 23990886
[TBL] [Abstract][Full Text] [Related]
4. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
[TBL] [Abstract][Full Text] [Related]
5. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.
Homans J; Christensen S; Stiller T; Wang CH; Mack W; Anastos K; Minkoff H; Young M; Greenblatt R; Cohen M; Strickler H; Karim R; Spencer LY; Operskalski E; Frederick T; Kovacs A
J Acquir Immune Defic Syndr; 2012 May; 60(1):99-110. PubMed ID: 22517416
[TBL] [Abstract][Full Text] [Related]
6. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women.
Natividad-Villanueva GU; Santiago E; Manalastas RM; Brown HW; Ingersoll J; Caliendo AM; Mayer KH; Cu-Uvin S
Int J STD AIDS; 2003 Dec; 14(12):826-9. PubMed ID: 14678591
[TBL] [Abstract][Full Text] [Related]
8. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
[TBL] [Abstract][Full Text] [Related]
9. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.
Nelson JAE; De Paris K; Ramirez C; Edmonds A; Mollan KR; Bay CP; Compliment K; Herold BC; Anastos K; Minkoff H; Kassaye S; Seidman DL; French AL; Golub ET; Sheth AN; Ochsenbauer C; Swanstrom R; Eron JJ; Adimora AA
AIDS; 2020 Jan; 34(1):39-46. PubMed ID: 31483374
[TBL] [Abstract][Full Text] [Related]
10. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
[TBL] [Abstract][Full Text] [Related]
11. Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
Nowicki MJ; Laskus T; Nikolopoulou G; Radkowski M; Wilkinson J; Du WB; Rakela J; Kovacs A
J Infect Dis; 2005 Nov; 192(9):1557-65. PubMed ID: 16206070
[TBL] [Abstract][Full Text] [Related]
12. Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.
Herold BC; Keller MJ; Shi Q; Hoover DR; Carpenter CA; Huber A; Parikh UM; Agnew KJ; Minkoff H; Colie C; Nowicki MJ; DʼSouza G; Watts DH; Anastos K
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):485-93. PubMed ID: 23591635
[TBL] [Abstract][Full Text] [Related]
13. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
[TBL] [Abstract][Full Text] [Related]
14. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women.
Uvin SC; Caliendo AM
Obstet Gynecol; 1997 Nov; 90(5):739-43. PubMed ID: 9351756
[TBL] [Abstract][Full Text] [Related]
15. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women.
Schoenfisch AL; Dollard SC; Amin M; Gardner LI; Klein RS; Mayer K; Rompalo A; Sobel JD; Cannon MJ
J Med Microbiol; 2011 Jun; 60(Pt 6):768-774. PubMed ID: 21393456
[TBL] [Abstract][Full Text] [Related]
17. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
[TBL] [Abstract][Full Text] [Related]
18. Cervicovaginal shedding of hepatitis C viral RNA is associated with the presence of menstrual or other blood in cervicovaginal fluids.
Wang CC; Cook L; Tapia KA; Holte S; Krows M; Bagabag A; Santos A; Corey L; Jerome KR
J Clin Virol; 2011 Jan; 50(1):4-7. PubMed ID: 20951635
[TBL] [Abstract][Full Text] [Related]
19. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.
Theiler RN; Farr SL; Karon JM; Paramsothy P; Viscidi R; Duerr A; Cu-Uvin S; Sobel J; Shah K; Klein RS; Jamieson DJ
Obstet Gynecol; 2010 Jun; 115(6):1150-1158. PubMed ID: 20502284
[TBL] [Abstract][Full Text] [Related]
20. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
